Update in lung cancer 2005

被引:6
作者
Jett, JR
Miller, YE
机构
[1] Denver Vet Affairs Med Ctr, Pulm & Crit Care Med Sect, Denver, CO 80220 USA
[2] Mayo Coll Med, Rochester, MN USA
[3] Univ Colorado, Denver, CO 80202 USA
[4] Hlth Sci Ctr, Denver, CO USA
关键词
D O I
10.1164/rccm.2601008
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:695 / 697
页数:3
相关论文
共 35 条
[1]   The effects of a smoking cessation intervention on 14.5-year mortality - A randomized clinical trial [J].
Anthonisen, NR ;
Skeans, MA ;
Wise, RA ;
Manfreda, J ;
Kanner, RE ;
Connett, JE .
ANNALS OF INTERNAL MEDICINE, 2005, 142 (04) :233-239
[2]   Measurement of hypoxia-related parameters in bronchial mucosa by use of optical spectroscopy [J].
Bard, MPL ;
Amelink, A ;
Hegt, VN ;
Graveland, WJ ;
Sterenborg, HJCM ;
Hoogsteden, HC ;
Aerts, JGJV .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 171 (10) :1178-1184
[3]   Early lung cancer detection using spiral computed tomography and positron emission tomography [J].
Bastarrika, G ;
García-Velloso, MJ ;
Lozano, MD ;
Montes, U ;
Torre, W ;
Spiteri, N ;
Campo, A ;
Seijo, L ;
Alcaide, AB ;
Pueyo, J ;
Cano, D ;
Vivas, I ;
Cosín, O ;
Domínguez, P ;
Serra, P ;
Richter, JA ;
Montuenga, L ;
Zulueta, JJ .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 171 (12) :1378-1383
[4]   Epidermal growth factor receptor mutations and gene amplification in non-small-cell lung cancer: Molecular analysis of the IDEAL/INTACT gefitinib trials [J].
Bell, DW ;
Lynch, TJ ;
Haserlat, SM ;
Harris, PL ;
Okimoto, RA ;
Brannigan, BW ;
Sgroi, DC ;
Muir, B ;
Riemenschneider, MJ ;
Iacona, RB ;
Krebs, AD ;
Johnson, DH ;
Giaccone, G ;
Herbst, RS ;
Manegold, C ;
Fukuoka, M ;
Kris, MG ;
Baselga, J ;
Ochs, JS ;
Haber, DA .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (31) :8081-8092
[5]   Lung adenocarcinoma global profiling identifies type II transforming growth factor-β receptor as a repressor of invasiveness [J].
Borczuk, AC ;
Kim, HK ;
Yegen, HA ;
Friedman, RA ;
Powell, CA .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 172 (06) :729-737
[6]  
CAPPUZZO F, 2005, JNCI-J NATL CANCER I, V97, P1
[7]   3p microsatellite alterations in exhaled breath condensate from patients with non-small cell lung cancer [J].
Carpagnano, GE ;
Foschino-Barbaro, MP ;
Mulé, G ;
Resta, O ;
Tommasi, S ;
Mangia, A ;
Carpagnano, F ;
Stea, G ;
Susca, A ;
Di Gioia, G ;
De Lena, M ;
Paradiso, A .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 172 (06) :738-744
[8]   CD4+CD25+ regulatory T lymphocytes in malignant pleural effusion [J].
Chen, YQ ;
Shi, HZ ;
Qin, XJ ;
Mo, WN ;
Liang, XD ;
Huang, ZX ;
Yang, HB ;
Wu, C .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 172 (11) :1434-1439
[9]   Risk of lung cancer among white and black relatives of individuals with early-onset lung cancer [J].
Coté, ML ;
Kardia, SLR ;
Wenzlaff, AS ;
Ruckdeschel, JC ;
Schwartz, AG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (24) :3036-3042
[10]   Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib [J].
Eberhard, DA ;
Johnson, BE ;
Amler, LC ;
Goddard, AD ;
Heldens, SL ;
Herbst, RS ;
Ince, WL ;
Jänne, PA ;
Januario, T ;
Johnson, DH ;
Klein, P ;
Miller, VA ;
Ostland, MA ;
Ramies, DA ;
Sebisanovic, D ;
Stinson, JA ;
Zhang, YR ;
Seshagiri, S ;
Hillan, KJ .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (25) :5900-5909